Cargando…
Anticancer efficacy of monotherapy with antibodies to SIRPα/SIRPβ1 mediated by induction of antitumorigenic macrophages
The interaction of signal regulatory protein α (SIRPα) on macrophages with CD47 on cancer cells is thought to prevent antibody (Ab)-dependent cellular phagocytosis (ADCP) of the latter cells by the former. Blockade of the CD47-SIRPα interaction by Abs to CD47 or to SIRPα, in combination with tumor-t...
Autores principales: | Sakamoto, Mariko, Murata, Yoji, Tanaka, Daisuke, Kakuchi, Yuka, Okamoto, Takeshi, Hazama, Daisuke, Saito, Yasuyuki, Kotani, Takenori, Ohnishi, Hiroshi, Miyasaka, Masayuki, Fujisawa, Masato, Matozaki, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740680/ https://www.ncbi.nlm.nih.gov/pubmed/34949714 http://dx.doi.org/10.1073/pnas.2109923118 |
Ejemplares similares
-
Anti‐human SIRPα antibody is a new tool for cancer immunotherapy
por: Murata, Yoji, et al.
Publicado: (2018) -
Targeting of SIRPα as a potential therapy for Langerhans cell histiocytosis
por: Okamoto, Takeshi, et al.
Publicado: (2023) -
Microglial SIRPα regulates the emergence of CD11c(+) microglia and demyelination damage in white matter
por: Sato-Hashimoto, Miho, et al.
Publicado: (2019) -
Targeting SIRPα in cancer
por: Ho, Jenny M., et al.
Publicado: (2013) -
Prion pathogenesis is unaltered in the absence of SIRPα-mediated "don't-eat-me" signaling
por: Nuvolone, Mario, et al.
Publicado: (2017)